Preclinical and clinical research relating to: aetiology, physiology and pharmacology, pathophysiology, genetics and genomics, diagnostics, biomarkers, epidemiology

Crystal-induced arthritis – e.g. gout, hyperuricaemia

Infectious arthritis – e.g. Lyme disease, viral arthritis

Metabolic and bone disease – e.g. osteoporosis, Paget disease

Inflammatory arthritis – e.g. as part of a systemic disease, osteonecrosis, TMJ

Osteoarthritis

Rheumatoid arthritis including juvenile RA

Soft tissue and regional rheumatic disease – e.g. fibromyalgia, tendonitis, Dupuytren contracture

Spondyloarthropathies – e.g. ankylosing spondylitis, psoriatic arthritis

Systemic rheumatic disease – e.g. dermatomyositis, polymyalgia, scleroderma, Sjogren syndrome, SLE, Raynaud phenomenon, lupus nephritis, haemochromatosis

Vasculitis – e.g. Behcet disease, Churg-Strauss syndrome, giant cell arteritis, polyarteritis nodosa

New and emerging drug treatments: basic and clinical research, place in therapy, optimal use, adverse effects.